Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653
Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653
Price:
20.48
CNY
-0.24%
Market Closed
Market Cap:
¥3.7B
Relative Value
The Relative Value of one
Yantai Zhenghai Bio-Tech Co Ltd
stock under the Base Case scenario is
16.88
CNY.
Compared to the current market price of 20.48 CNY,
Yantai Zhenghai Bio-Tech Co Ltd
is
Overvalued by 18%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
16.88
CNY
Overvaluation 18%
Multiples Across Competitors
Competitors Multiples
Yantai Zhenghai Bio-Tech Co Ltd Competitors
Yantai Zhenghai Bio-Tech Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Yantai Zhenghai Bio-Tech Co Ltd
SZSE:300653
|
3.7B CNY | 10.6 | 47.9 | 45.4 | 45.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
397B USD | 6.7 | 169.3 | 16.4 | 23.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
200.9B USD | 5.5 | 26.1 | 15 | 15 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
189.6B USD | 6.4 | 22.2 | 15.1 | 15.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
118.6B USD | 10 | 30.3 | 23.2 | 24.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.9B USD | 5.7 | 18.2 | 13.7 | 15.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
74.1B AUD | 3.3 | 17.2 | 11.8 | 14.7 | |
| NL |
|
argenx SE
XBRU:ARGX
|
44.2B EUR | 14.5 | 34 | 58.5 | 60.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
